Eli Lilly Other Operating Income or Expenses 2010-2024 | LLY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Eli Lilly annual other operating income or expenses for 2023 were $-0.068B, a 72.32% decline from 2022.
Eli Lilly annual other operating income or expenses for 2022 were $-0.245B, a 22.62% decline from 2021.
Eli Lilly annual other operating income or expenses for 2021 were $-0.316B, a 140.93% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Eli Lilly annual other operating income or expenses for 2023 were $-0.068B, a 72.32% decline from 2022.
Eli Lilly annual other operating income or expenses for 2022 were $-0.245B, a 22.62% decline from 2021.
Eli Lilly annual other operating income or expenses for 2021 were $-0.316B, a 140.93% increase from 2020.